SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
PharmaEssentia Acquires Certain Asian Rights for Dermatology Preparations of Kinex Pharmaceuticals' Promising Novel Dual Src/Pretubulin Inhibitor, KX01